Figure 6. SWNT-cMORF-(²²⁵Ac)DOTA can be used as an effective agent in multistep therapy of disseminated lymphoma.

Mice previously implanted with luciferase-transfected Daudi lymphoma cells were injected with 5mg/ml luciferin and imaged after a 5 minute delay. The parameters are equivalent for all images, but as a trade-off, this leads to saturation that disallows quantification. Mice were treated with multistep therapy as previously noted and imaged at days 0, 3, 6, and 15 post treatment. Growth, Rituximab therapy, isotype high-dose radiation, and blocked 2-step controls are provided. For further controls see also Figure S8.